ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Sampre Nutritions allotted 1,770,710 equity shares at ₹42 each to promoters upon unsecured loan conversion. This capital issuance totals ₹7.44 Crore.
Sampre Nutritions Limited conducted its 35th Annual General Meeting on September 4, 2026. Shareholders considered the adoption of financial statements and a revision in director remuneration.
Sampre Nutritions received BSE in-principal approval for a preferential issue of 17.71 lakh equity shares. The issue involves converting ₹7.44 Crore of unsecured loans into equity.
Sampre Nutritions Ltd has filed its quarterly shareholding pattern for the period ended December 31, 2025, as mandated by SEBI Regulation 31.
Sampre Nutritions has filed its Annual Report for the financial year 2025-26, including the notice for its 35th Annual General Meeting.
Sampre Nutritions Limited will hold its 35th Annual General Meeting on 04 September 2026 via video conferencing to transact ordinary and special business.
Sampre Nutritions Ltd reported revenue from operations of ₹14.8 Cr (+35.8% YoY) and net profit of ₹0.7 Cr (+0.0% YoY) for Q1 FY27.
Sampre Nutritions Limited scheduled a board meeting for August 5, 2026. The board will consider June 2026 quarterly results and director remuneration increases.
Sampre Nutritions has scheduled a board meeting for August 5, 2026. The board will consider Q1 results and a proposal to increase director remuneration.
Sampre Nutritions Limited disclosed ₹27,000 in fines for delayed financial and annual report submissions. The penalties were paid following observations in the secretarial compliance report.
Sampre Nutritions Limited commemorated a 30-year business association with Mondelez International. This voluntary disclosure marks a long-standing commercial relationship without altering existing financial or contractual terms.
Sampre Nutritions Ltd reported revenue from operations of ₹15.1 Cr (+93.6% YoY) and net profit of ₹1.3 Cr for Q4 FY26.
Sampre Nutritions Limited reported standalone annual revenue of ₹44.06 Crore for FY26. The Board approved audited results with an unmodified auditor opinion for the fiscal year.
Sampre Nutritions Limited scheduled a board meeting on May 29, 2026. Directors will consider and approve audited financial results for the quarter and year ended March 2026.
Sampre Nutritions Limited announced that shareholders approved Pradeep Narendra Poddar's appointment as a Non-Executive Director via postal ballot. The resolution passed with requisite majority.
Sampre Nutritions Limited has issued a postal ballot notice to seek shareholder approval for the appointment of Pradeep Narendra Poddar as a Non-Executive Non-Independent Director. The remote e-voting period runs from April 11, 2026, to May 10, 2026. This is a routine regulatory procedure for director appointments.
Sampre Nutritions Ltd reported net profit of ₹0.6 Cr for Q3 FY26.